Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns

BACKGROUND: Current diagnostic tools for prostate cancer lack specificity and sensitivity for detecting very early lesions. DNA methylation is a stable genomic modification that is detectable in peripheral patient fluids such as urine and blood plasma that could serve as a non-invasive diagnostic bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirby, Marie K., Ramaker, Ryne C., Roberts, Brian S., Lasseigne, Brittany N., Gunther, David S., Burwell, Todd C., Davis, Nicholas S., Gulzar, Zulfiqar G., Absher, Devin M., Cooper, Sara J., Brooks, James D., Myers, Richard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392915/
https://www.ncbi.nlm.nih.gov/pubmed/28412973
http://dx.doi.org/10.1186/s12885-017-3252-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392915/
https://www.ncbi.nlm.nih.gov/pubmed/28412973
http://dx.doi.org/10.1186/s12885-017-3252-2

Ejemplares similares